US Stock MarketDetailed Quotes
EW Edwards Lifesciences
- 66.580
- +0.810+1.23%
Close Sep 27 16:00 ET
- 66.985
- +0.405+0.61%
Post 20:01 ET
40.11BMarket Cap27.40P/E (TTM)
67.320High65.850Low5.17MVolume66.200Open65.770Pre Close344.24MTurnover0.87%Turnover Ratio28.95P/E (Static)602.40MShares96.12052wk High5.39P/B39.71BFloat Cap58.93052wk Low--Dividend TTM596.36MShs Float131.730Historical High--Div YieldTTM2.24%Amplitude1.000Historical Low66.622Avg Price1Lot Size
About Edwards Lifesciences Company
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Company Profile
SymbolEW
Company NameEdwards Lifesciences
Listing DateMar 27, 2000
Founded1958
CEOMr. Bernard J. Zovighian
MarketNYSE
Employees19800
Fiscal Year Ends12-31
Address1 Edwards Way
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92614
Phone1-949-250-2500
Websitehttp://www.edwards.com
Company Executives
- Name
- Position
- Salary
- Bernard J. Zovighian
- Director and Chief Executive Officer
- 12.87M
- Scott B. Ullem
- Corporate Vice President and Chief Financial Officer
- 5.95M
- Wayne Markowitz
- General Manager and Senior Vice President, Surgical Structural Heart
- --
- Andrew M. Dahl
- Principal Accounting Officer, Senior Vice President and Corporate Controller
- --
- Daveen Chopra
- Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies
- --
- Daniel J. Lippis
- Corporate Vice President, JAPAC
- --
- Catherine M. Szyman
- Corporate Vice President, Critical Care
- 4.34M
- Donald E. Bobo,Jr
- Corporate Vice President
- 4.29M
- Larry L. Wood
- Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart
- 5.40M
- Jean-Luc M. Lemercier
- Corporate Vice President, Europe, Middle East, Africa, Canada and Latin America
- --
- Nicholas J. Valeriani
- Chairman of the Board
- 347.97K
- Dr. David T. Feinberg, M.D.,PhD
- Director
- --
- Steven R. Loranger
- Independent Director
- 335.06K
- Paul A. Laviolette
- Independent Director
- 329.97K
- Kieran T. Gallahue
- Independent Director
- 335.06K
- Leslie C. Davis
- Independent Director
- --
- Ramona Sequeira
- Independent Director
- 334.97K
- Leslie Stone Heisz
- Independent Director
- 356.42K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data